🇺🇸 FDA
Patent

US 8003112

Meningococcal and pneumococcal conjugate vaccine and method of using same

granted A61KA61K2039/6068A61K2039/70

Quick answer

US patent 8003112 (Meningococcal and pneumococcal conjugate vaccine and method of using same) held by THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH
Grant date
Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2039/6068, A61K2039/70, A61K39/092, A61K39/095